| Dr Nathan R Weldon, MD | |
|
133 Morongo Ave, Banning, CA 92220-3813 | |
| (951) 849-4761 | |
| Not Available |
| Full Name | Dr Nathan R Weldon |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 133 Morongo Ave, Banning, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427197235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A95657 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
Size really does matter when laboratories specify preclinical MRI imaging technology – in fact space is at such a premium that insufficient floor area often precludes purchase. The high field Flexiscan and Powerscan cryogen-free systems from MR Solutions have a compact design and are simply wheeled in and connected to the mains and other services whilst providing state of the art imaging.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Target will help its guests reach their well-being goals by serving as prevention and treatment headquarters throughout this upcoming cold and flu season. Beginning Sept. 1, 2010, the flu vaccine will be available at more than 1,600 Target Pharmacy and Target Clinic locations nationwide.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping. The methodology enabled researchers to detect complex forms of genomic variation, critically important for their association with human disease, but previously difficult to detect.
Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD). Salsalate prevented the accumulation of tau in the brain and protected against cognitive impairments resembling impairments seen in Alzheimer's disease and FTD.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan R Weldon, MD 133 Morongo Ave, Banning, CA 92220-3813 Ph: (909) 648-6283 | Dr Nathan R Weldon, MD 133 Morongo Ave, Banning, CA 92220-3813 Ph: (951) 849-4761 |
News Archive
Size really does matter when laboratories specify preclinical MRI imaging technology – in fact space is at such a premium that insufficient floor area often precludes purchase. The high field Flexiscan and Powerscan cryogen-free systems from MR Solutions have a compact design and are simply wheeled in and connected to the mains and other services whilst providing state of the art imaging.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Target will help its guests reach their well-being goals by serving as prevention and treatment headquarters throughout this upcoming cold and flu season. Beginning Sept. 1, 2010, the flu vaccine will be available at more than 1,600 Target Pharmacy and Target Clinic locations nationwide.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping. The methodology enabled researchers to detect complex forms of genomic variation, critically important for their association with human disease, but previously difficult to detect.
Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD). Salsalate prevented the accumulation of tau in the brain and protected against cognitive impairments resembling impairments seen in Alzheimer's disease and FTD.
› Verified 3 days ago
Dr. Theodore Eugene Wyman, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 264 N Highland Springs Ave, Suite 5a, Banning, CA 92220 Phone: 951-769-0079 |